Article Text

Use of lamotrigine to treat paroxysmal kinesigenic choreoathetosis
  1. A C PEREIRA,
  2. W J LOO
  1. Department of Clinical Neurology, Ipswich Hospital, Ipswich, IP4 5PD, UK
  2. Department of Paediatrics
  3. Department of Clinical Neurology, Ipswich Hospital, Ipswich, IP4 5PD, UK
  1. Dr S J Wroe
  1. M BAMFORD
  1. Department of Clinical Neurology, Ipswich Hospital, Ipswich, IP4 5PD, UK
  2. Department of Paediatrics
  3. Department of Clinical Neurology, Ipswich Hospital, Ipswich, IP4 5PD, UK
  1. Dr S J Wroe
  1. S J WROE
  1. Department of Clinical Neurology, Ipswich Hospital, Ipswich, IP4 5PD, UK
  2. Department of Paediatrics
  3. Department of Clinical Neurology, Ipswich Hospital, Ipswich, IP4 5PD, UK
  1. Dr S J Wroe

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We report the use of lamotrigine to treat paroxysmal kinesigenic choreoathetosis. Paroxysmal cases of kinesigenic choreoathetosis were first described in 1962 by Lishmanet al 1 and the term “paroxysmal kinesigenic choreoathetosis” was first coined by Kertesz2 in 1967. Recently, a more universal and potentially useful classification of these disorders has been proposed amending the terminology to “paroxysmal kinesigenic dyskinesia”.3 However, we have used the more familiar terminology for our patient as it is more precise. The clinical features of paroxysmal kinesigenic choreoathetosis have been reviewed by Marsden and Luders.4 …

View Full Text